固体脂质纳米粒
溶解
Zeta电位
分散性
粒径
色谱法
化学
溶解度
水溶液
溶剂
埃替拉韦
纳米颗粒
肺表面活性物质
核化学
化学工程
材料科学
纳米技术
有机化学
生物化学
物理化学
病毒载量
工程类
医学
家庭医学
抗逆转录病毒疗法
人类免疫缺陷病毒(HIV)
作者
Pavan Kommavarapu,Arthanareeswari Maruthapillai,K. Palanisamy
摘要
Purpose: To enhance the aqueous solubility and dissolution rate of elvitegravir (EVG) by formulating the drug as solid lipid nanoparticles (SLNs) using solvent injection method.Methods: EVG-loaded SLNs were prepared by solvent injection method. Four different formulations of SLN were prepared using gelucire - 44/14 as lipid core in ethanol, soya lecithin as emulsifier, and polysorbate 80 as surfactant in the aqueous phase. The SLNs were characterized for various physical properties, including particle size, zeta potential, polydispersity, release profile and entrapment efficiency.Results: The yield of SLNs was in the range 151.0 ± 2.4 to 199.1 ± 2.7 nm. Significant changes were observed in mean particle size (nm), Z - potential (mV) and polydispersity index (PDI) of the SLNs by varying the concentration of cryoprotectant. EVG – SLNs demonstrated a 800 – 1030-fold enhancement in aqueous solubility compared with plain EVG. The dissolution efficiency (DE) for SLNs was > 63 % in all cases and increased up to 83 % with increasing lipid load.Conclusion: Successful preparation and characterization of elvitegravir–loaded solid lipid nanoparticles by solvent injection method has been accomplished in this study.Keywords: Elvitegravir, Solid lipid nanoparticles, Cryoprotectant, Lipid load, Entrapment efficiency
科研通智能强力驱动
Strongly Powered by AbleSci AI